These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
544 related items for PubMed ID: 12940806
1. Botulinum toxin type A as an effective prophylactic treatment in primary headache disorders. Blumenfeld A. Headache; 2003 Sep; 43(8):853-60. PubMed ID: 12940806 [Abstract] [Full Text] [Related]
2. Botulinum toxin A for prophylactic treatment of migraine and tension headaches in adults: a meta-analysis. Jackson JL, Kuriyama A, Hayashino Y. JAMA; 2012 Apr 25; 307(16):1736-45. PubMed ID: 22535858 [Abstract] [Full Text] [Related]
3. Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial. Mathew NT, Frishberg BM, Gawel M, Dimitrova R, Gibson J, Turkel C, BOTOX CDH Study Group. Headache; 2005 Apr 25; 45(4):293-307. PubMed ID: 15836565 [Abstract] [Full Text] [Related]
4. [Botulinum toxin injections for chronic migraine in adolescents - an early therapeutic option in the transition from neuropaediatrics to neurology]. Bernhard MK, Bertsche A, Syrbe S, Weise S, Merkenschlager A. Fortschr Neurol Psychiatr; 2014 Jan 25; 82(1):39-42. PubMed ID: 24446117 [Abstract] [Full Text] [Related]
5. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study. Dodick DW, Mauskop A, Elkind AH, DeGryse R, Brin MF, Silberstein SD, BOTOX CDH Study Group. Headache; 2005 Apr 25; 45(4):315-24. PubMed ID: 15836567 [Abstract] [Full Text] [Related]
6. Botulinum toxin type a in the prophylactic treatment of transformed migraine in Taiwanese patients: a review of 30 consecutive cases. Liu YC, Fuh JL, Chen RC, Lin KP, Wang SJ. J Chin Med Assoc; 2007 Dec 25; 70(12):535-40. PubMed ID: 18194894 [Abstract] [Full Text] [Related]
7. Botulinum neurotoxin type A in the preventive treatment of refractory headache: a review of 100 consecutive cases. Tepper SJ, Bigal ME, Sheftell FD, Rapoport AM. Headache; 2004 Sep 25; 44(8):794-800. PubMed ID: 15330826 [Abstract] [Full Text] [Related]
8. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues. Cady R, Schreiber C. Headache; 2008 Jun 25; 48(6):900-13. PubMed ID: 18047501 [Abstract] [Full Text] [Related]
9. Botulinum toxin type A as a migraine preventive treatment. For the BOTOX Migraine Clinical Research Group. Silberstein S, Mathew N, Saper J, Jenkins S. Headache; 2000 Jun 25; 40(6):445-50. PubMed ID: 10849039 [Abstract] [Full Text] [Related]
10. Botulinum neurotoxin for the treatment of migraine and other primary headache disorders: from bench to bedside. Dodick DW. Headache; 2003 Jun 25; 43 Suppl 1():S25-33. PubMed ID: 12887391 [Abstract] [Full Text] [Related]
11. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study. Aurora SK, Gawel M, Brandes JL, Pokta S, Vandenburgh AM, BOTOX North American Episodic Migraine Study Group. Headache; 2007 Apr 25; 47(4):486-99. PubMed ID: 17445098 [Abstract] [Full Text] [Related]
12. Botulinum toxin type A (BOTOX) for treatment of migraine headaches: an open-label study. Binder WJ, Brin MF, Blitzer A, Schoenrock LD, Pogoda JM. Otolaryngol Head Neck Surg; 2000 Dec 25; 123(6):669-76. PubMed ID: 11112955 [Abstract] [Full Text] [Related]
13. Long-term benefits of botulinum toxin type A (BOTOX) in chronic daily headache: a five-year long experience. Farinelli I, Coloprisco G, De Filippis S, Martelletti P. J Headache Pain; 2006 Dec 25; 7(6):407-12. PubMed ID: 17149565 [Abstract] [Full Text] [Related]
14. Botulinum toxin type A and acute drug costs in migraine with triptan overuse. Christie SN, Giammarco R, Gawel M, Mackie G, Gladstone J, Becker WJ. Can J Neurol Sci; 2010 Sep 25; 37(5):588-94. PubMed ID: 21059503 [Abstract] [Full Text] [Related]
15. Humanistic, utilization, and cost outcomes associated with the use of botulinum toxin for treatment of refractory migraine headaches in a managed care organization. Mitchell MP, Schaecher K, Cannon HE, Speckman M. J Manag Care Pharm; 2008 Jun 25; 14(5):442-50. PubMed ID: 18597573 [Abstract] [Full Text] [Related]
16. Botulinum toxin type A for migraine prophylaxis in the Japanese population: an open-label prospective trial. Suzuki K, Iizuka T, Sakai F. Intern Med; 2007 Jun 25; 46(13):959-63. PubMed ID: 17603233 [Abstract] [Full Text] [Related]
17. Botulinum toxin A injection into corrugator muscle for frontally localised chronic daily headache or chronic tension-type headache. de Ru JA, Buwalda J. J Laryngol Otol; 2009 Apr 25; 123(4):412-7. PubMed ID: 18588738 [Abstract] [Full Text] [Related]
18. Botulinum toxin type A for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial. Silberstein SD, Stark SR, Lucas SM, Christie SN, Degryse RE, Turkel CC, BoNTA-039 Study Group. Mayo Clin Proc; 2005 Sep 25; 80(9):1126-37. PubMed ID: 16178492 [Abstract] [Full Text] [Related]
19. Single-site botulinum toxin type a injection for elimination of migraine trigger points. Behmand RA, Tucker T, Guyuron B. Headache; 2003 Sep 25; 43(10):1085-9. PubMed ID: 14629244 [Abstract] [Full Text] [Related]
20. The efficiency of botulinum toxin type A for the treatment of masseter muscle pain in patients with temporomandibular joint dysfunction and tension-type headache. Pihut M, Ferendiuk E, Szewczyk M, Kasprzyk K, Wieckiewicz M. J Headache Pain; 2016 Sep 25; 17():29. PubMed ID: 27011213 [Abstract] [Full Text] [Related] Page: [Next] [New Search]